Drug Approval | August 03, 2022
Strides receives USFDA approval for Cyclosporine Softgel Capsules
Strides is the first Indian company to get approval for the product.
Strides is the first Indian company to get approval for the product.
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
Perrigo expects to launch Omeprazole Minis later this year
The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Pradaxa Capsules of Boehringer lngelheim
Merzee is a generic equivalent of Taytulla of Allergan Pharmaceuticals International
To be marketed by Strides Pharma Inc. in the US market
According to the Indian Journal of Medical Research in 2018, the estimated prevalence of pre-diabetes in India is 14%, which means that one out of six Indians is pre-diabetic
The capsules are the generic version of the reference listed drug Mycobutin
Dabigatran Etexilate capsules are indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, and for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE)
The company is eligible for 180 days of generic drug exclusivity for Lenalidomide capsules, 2.5 mg and 20 mg
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
